Merve Tepe, PhD banner
Merve Tepe, PhD

Merve Tepe, PhD Bluesky Profile Stats

@mervetepephd.bsky.socialEnglish flagEnglishScienceTier C
View on Bluesky
Account age: 3 years (joined June 2023)

Merve Tepe, PhD Bluesky stats, updated continuously. @mervetepephd.bsky.social has 3,615 followers and 517 posts on Bluesky. Account age: 3 years (joined June 2023).

Followers
3.6K
Growth (7d)
-
Following
3.5K
Posts
517~0.4/day
Influence
26

Follower growth

Not enough history yet - growth is tracked from first discovery.

Bio

PhD MICROBIOLOGIST AMR, Biofilms, Phage Therapy, Drug Design and some other similar topics 🤫🔜 @remissionbiome.bsky.social team @renegaderesearch.bsky.social volunteer DEFEND SCIENCE, RESIST IGNORANCE 🚫 #SonKale06 Ankara

Notable followers

The biggest accounts in our directory following @mervetepephd.bsky.social.

Merve Tepe, PhD on Bluesky - frequently asked questions

How many followers does Merve Tepe, PhD have on Bluesky?
Merve Tepe, PhD (@mervetepephd.bsky.social) has 3,615 followers on Bluesky. The count is refreshed continuously from the public AT Protocol.
When did Merve Tepe, PhD join Bluesky, and how old is the account?
Merve Tepe, PhD joined Bluesky in June 2023. The @mervetepephd.bsky.social account is 3 years old. Searches for Merve Tepe, PhD age often mean a personal age, which we do not publish. The figure here is the account age only.
How many posts has Merve Tepe, PhD published?
Merve Tepe, PhD has published 517 posts on Bluesky. That is about 0.4 posts per day over the life of the account.
Is Merve Tepe, PhD verified on Bluesky?
@mervetepephd.bsky.social does not currently show a Bluesky verification. Many real accounts on Bluesky are unverified, since verification is still rolling out.
What does Merve Tepe, PhD post about?
Merve Tepe, PhD is classified under Science in our directory. Bio: "PhD MICROBIOLOGIST AMR, Biofilms, Phage Therapy, Drug Design and some other similar topics 🤫🔜 @remissionbiome.bsky.social team @renegaderesearch.bsky.social volunteer DEFEND SCIENCE, RESIST IGNOR".